Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Mind Medicine (MindMed) Inc N.MMED


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MNMD)

MindMed to Present at Upcoming May Medical Conferences

Business Wire 21 hours ago

MindMed to Present at Upcoming April Medical Conferences

Business Wire April 2, 2024

MindMed Announces Voluntary Delisting from Cboe Canada

Business Wire April 1, 2024

MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference

Business Wire March 11, 2024

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

Business Wire March 7, 2024

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

Business Wire March 7, 2024

MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120

Business Wire March 1, 2024

MindMed Reports 2023 Financial Results and Business Updates

Business Wire February 28, 2024

MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update

Business Wire February 22, 2024
View More News ››

Opinion & Analysis (NDAQ:MNMD)

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Broadway Gold ramps up exploration at Madison Mine

The Gold Report March 2, 2017
View More Opinion ››

Bullboard Posts (NDAQ:MNMD)

RE:mmed

You might have to call your broker to request a transfer to NSDQ otjerwise the shares will show up in your account but the values won'...
Starkicker - 13 days ago

RE:mmed

They'll just get transferred. You'll still own the same amount. Your account will probably show in USD though.
Starkicker - April 6, 2024

mmed

What will happen to my Canadian shares once MMED is only on the nasdaq?
dave1100 - April 4, 2024

RE:3 Month Predictions

Hell of a day! Big volume as well 
Bigmoneytalks - April 3, 2024

3 Month Predictions

Not a lot of chatter on the forum... It has been a nice jump in SP the last 3 weeks and holding at current prices. What are some...
Bigmoneytalks - March 27, 2024

Musk endorses Ketamine use

Mmed is the cream de La crme of psychedelics. Not selling until at least $20  But I think I.m going to be taking a full position...
mikesright - March 21, 2024
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. is a Canada-based intermediate land drilling contractor. The Company and its subsidiaries provide ...
View More »